Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan
Abstract Global vaccination against the coronavirus disease 2019 (COVID-19) is thought to be the most effective way to end or at least contain the COVID-19 pandemic. However, despite the good safety profiles and effectiveness of the available COVID-19 vaccines, rare but serious hematological complications have emerged, including thromboembolic outcomes with thrombocytopenia following the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) and Ad26.COV.2.S (Johnson & Johnson/Janssen) vaccines. Moreover, COVID-19 vaccination may be linked to the development of aplastic anemia (AA). We discuss four cases of AA that arose after COVID-19 vaccination in our hospital and two other such cases identified in our literature review..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:117 |
|---|---|
| Enthalten in: |
International journal of hematology - 117(2022), 1 vom: 04. Sept., Seite 149-152 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chen, Chia-Yu [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Aplastic anemia |
|---|
| Anmerkungen: |
© Japanese Society of Hematology 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s12185-022-03445-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2080233602 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2080233602 | ||
| 003 | DE-627 | ||
| 005 | 20230515070302.0 | ||
| 007 | tu | ||
| 008 | 230131s2022 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12185-022-03445-2 |2 doi | |
| 035 | |a (DE-627)OLC2080233602 | ||
| 035 | |a (DE-He213)s12185-022-03445-2-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Chen, Chia-Yu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Japanese Society of Hematology 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a Abstract Global vaccination against the coronavirus disease 2019 (COVID-19) is thought to be the most effective way to end or at least contain the COVID-19 pandemic. However, despite the good safety profiles and effectiveness of the available COVID-19 vaccines, rare but serious hematological complications have emerged, including thromboembolic outcomes with thrombocytopenia following the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) and Ad26.COV.2.S (Johnson & Johnson/Janssen) vaccines. Moreover, COVID-19 vaccination may be linked to the development of aplastic anemia (AA). We discuss four cases of AA that arose after COVID-19 vaccination in our hospital and two other such cases identified in our literature review. | ||
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Coronavirus disease 2019 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Severe acute respiratory syndrome coronavirus-2 vaccine | |
| 650 | 4 | |a Vaccination | |
| 650 | 4 | |a Aplastic anemia | |
| 700 | 1 | |a Chen, Tzu-Ting |4 aut | |
| 700 | 1 | |a Hsieh, Ching-Yun |4 aut | |
| 700 | 1 | |a Lien, Ming-Yu |4 aut | |
| 700 | 1 | |a Yeh, Su-Peng |4 aut | |
| 700 | 1 | |a Chen, Chi-Ching |0 (orcid)0000-0002-6070-3838 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of hematology |d Springer Nature Singapore, 1991 |g 117(2022), 1 vom: 04. Sept., Seite 149-152 |w (DE-627)170577996 |w (DE-600)1076875-0 |w (DE-576)105258091 |x 0925-5710 |7 nnns |
| 773 | 1 | 8 | |g volume:117 |g year:2022 |g number:1 |g day:04 |g month:09 |g pages:149-152 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s12185-022-03445-2 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 951 | |a AR | ||
| 952 | |d 117 |j 2022 |e 1 |b 04 |c 09 |h 149-152 | ||